Medline, Inc. (MDLN)
35.86
+0.75
(+2.14%)
USD |
NASDAQ |
Sep 02, 10:57
Medline Research and Development Expense (Annual) : 80.00M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 80.00M |
| December 31, 2024 | 67.00M |
| Date | Value |
|---|---|
| December 31, 2023 | 60.00M |
| December 31, 2022 | 58.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| ICU Medical, Inc. | 87.50M |
| Insulet Corp. | 301.10M |
| Abbott Laboratories | 2.889B |
| AngioDynamics, Inc. | 29.45M |
| Alphatec Holdings, Inc. | 76.27M |